Otros idiomas Caplin Point Laboratories Limited NSE India S.E.

Acciones

CAPLIPOINT

INE475E01026

Mercado cerrado - NSE India S.E. Otros sitios de cotización 13:43:51 17/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1.341 ^INR	-1,65 %		+5,41 %	-1,10 %

16/05	Caplin Point Laboratories buscará adquisiciones	CI
16/05	Transcript : Caplin Point Laboratories Limited, Q4 2024 Earnings Call, May 16, 2024

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Caplin Point Laboratories to Seek Acquisitions	16/05
Caplin Point Laboratories Limited Declares an Interim Dividend for the Financial Year Ended March 31, 2024	16/05
Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	16/05
Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	06/05
Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	16/04
Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	28/03
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	28/03
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	27/03
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	27/03
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	08/01
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	08/01
Caplin Point Laboratories Limited Announces Resignation of Hero Velladurai as President, R&D	14/12
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	22/09/23
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	04/09/23
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/08/23
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	07/08/23
Caplin Point Laboratories to Incorporate Step-Down Subsidiary in US	03/08/23
Caplin Point Unit Gets US FDA Nod for Muscle Relaxant	12/06/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Caplin Point Laboratories Limited NSE India S.E.

Acciones

CAPLIPOINT

INE475E01026

Otros idiomas

Filtros